Dexrazoxane Preserved Cardiac Function in Children Undergoing Chemotherapy for AML
A study found that dexrazoxane, a cardioprotective drug, preserved cardiac function without compromising overall survival and event-free survival for pediatric patients with acute myeloid leukemia.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Cardiology | Chemotherapy | Children | Heart | Leukemia | Pediatrics | Study